Application

17221549 · Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer

Filed 2021-04-02 · Granted · Patent 11608330 (2023-03-21) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Kristin Ann Vajda Easy · CPC C07D 333/18 · The Institute of Cancer Research: Royal Cancer Hospital · Morgan, Lewis & Bockius LLP (SF)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

10.8 mo

to disposition 23.6 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.